Hypocretin administration as a treatment for human narcolepsy.
Siegel
J M
JM
D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology; D002352:Carrier Proteins / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D004285:Dogs; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D009290:Narcolepsy / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D009479:Neuropeptides / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D064446:Orexin Receptors; D000068797:Orexins; D017354:Point Mutation / Q000235:genetics; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide / Q000378:metabolism
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide